Literature DB >> 2613919

Antibiotic resistant fever associated with herpes simplex virus infection in neutropenic patients with haematological malignancy.

T P Baglin1, J J Gray, R E Marcus, T G Wreghitt.   

Abstract

The incidence of mucocutaneous herpes simplex virus infection confirmed by culture and occurring during febrile neutropenic episodes was determined in 43 patients with haematological malignancy. The outcome of 72 episodes of neutropenic fever was determined and correlated with the presence or absence of herpes simplex virus (HSV) infection. Twenty four patients had mucocutaneous HSV infection during at least one episode. In 24 episodes in which HSV was isolated only 12.5% of fevers responded to antibiotics and 75% of fevers were otherwise unexplained. Conversely, in 48 episodes of neutropenic fever in which HSV was not isolated 67% of fevers responded to antibiotics and only 8.3% were unexplained. The difference in incidence of antibiotic resistant fever in the two groups was significant. There was, therefore, a strong association between mucocutaneous HSV infection and antibiotic resistant fever in immunosuppressed neutropenic patients. As most HSV infections are the result of virus reactivation, establishing the HSV serological state of patients would identify those at risk of infection and hence those in whom the prophylactic use of acyclovir would be indicated.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2613919      PMCID: PMC502050          DOI: 10.1136/jcp.42.12.1255

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  10 in total

1.  Cellular immunity and herpesvirus infections in cardiac-transplant patients.

Authors:  K H Rand; L E Rasmussen; R B Pollard; A Arvin; T C Merigan
Journal:  N Engl J Med       Date:  1977-06-16       Impact factor: 91.245

Review 2.  Herpes simplex infections in hematologic malignancies.

Authors:  S A Muller; E C Herrmann; R K Winkelmann
Journal:  Am J Med       Date:  1972-01       Impact factor: 4.965

Review 3.  Rational basis for the choice of regimens for empirical therapy of sepsis in granulocytopenic patients.

Authors:  H Gaya
Journal:  Clin Haematol       Date:  1984-10

4.  Prospective randomized comparison of three antibiotic regimens for empirical therapy of suspected bacteremic infection in febrile granulocytopenic patients.

Authors:  J Klastersky; M P Glauser; S C Schimpff; S H Zinner; H Gaya
Journal:  Antimicrob Agents Chemother       Date:  1986-02       Impact factor: 5.191

5.  Septicaemia caused by viridans streptococci in neutropenic patients with leukaemia.

Authors:  J Cohen; J P Donnelly; A M Worsley; D Catovsky; J M Goldman; D A Galton
Journal:  Lancet       Date:  1983 Dec 24-31       Impact factor: 79.321

6.  Prophylaxis of herpes infections after bone-marrow transplantation by oral acyclovir.

Authors:  E Gluckman; J Lotsberg; A Devergie; X M Zhao; R Melo; M Gomez-Morales; T Nebout; M C Mazeron; Y Perol
Journal:  Lancet       Date:  1983-09-24       Impact factor: 79.321

7.  Acyclovir prophylaxis against herpes simplex virus infection in patients with leukemia. A randomized, double-blind, placebo-controlled study.

Authors:  R Saral; R F Ambinder; W H Burns; C M Angelopulos; D E Griffin; P J Burke; P S Lietman
Journal:  Ann Intern Med       Date:  1983-12       Impact factor: 25.391

8.  Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation: a double-blind trial.

Authors:  J C Wade; B Newton; C McLaren; N Flournoy; R E Keeney; J D Meyers
Journal:  Ann Intern Med       Date:  1982-03       Impact factor: 25.391

9.  Acyclovir prophylaxis against herpes virus infections in severely immunocompromised patients: randomised double blind trial.

Authors:  I M Hann; H G Prentice; H A Blacklock; M G Ross; D Brigden; A E Rosling; C Burke; D H Crawford; W Brumfitt; A V Hoffbrand
Journal:  Br Med J (Clin Res Ed)       Date:  1983-08-06

10.  Oral acyclovir prophylaxis against herpes simplex virus in non-Hodgkin lymphoma and acute lymphoblastic leukaemia patients receiving remission induction chemotherapy. A randomised double blind, placebo controlled trial.

Authors:  H Anderson; J H Scarffe; R N Sutton; E Hickmott; D Brigden; C Burke
Journal:  Br J Cancer       Date:  1984-07       Impact factor: 7.640

  10 in total
  3 in total

1.  HSV-1 clinical isolates with unique in vivo and in vitro phenotypes and insight into genomic differences.

Authors:  Robert J Danaher; Derrick E Fouts; Agnes P Chan; Yongwook Choi; Jessica DePew; Jamison M McCorrison; Karen E Nelson; Chunmei Wang; Craig S Miller
Journal:  J Neurovirol       Date:  2016-10-13       Impact factor: 2.643

2.  HSV-1 as well as HSV-2 is frequent in oral mucosal lesions of children on chemotherapy.

Authors:  Ritu Aggarwal; Deepak Bansal; Jasmine Naru; Manila Salaria; Anita Rana; Ranjana W Minz; Amita Trehan; R K Marwaha
Journal:  Support Care Cancer       Date:  2014-02-14       Impact factor: 3.603

Review 3.  Infections in neutropenic patients I: aetiology.

Authors:  P Engervall; M Björkholm
Journal:  Med Oncol       Date:  1995-12       Impact factor: 3.064

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.